In The News

“We found by optimizing nutrition and its delivery, we were able to reduce patients’ length of stay in the ICU and their length of ventilation by more than three days. This outcome is truly remarkable. For the first time ever, our study establishes a direct correlation between the way people receive nutrition in the ICU and the length of time they spend there.”
Medical Device & Technology, August 17, 2023

Compared with manual care for enterally fed ICU patients, a nutrition management platform guided by a robot met feeding goals more frequently and shortened stay and ventilation duration, according to results published in Clinical Nutrition. 
Healio, August 10, 2023

A comparative randomized study evaluating the performance of the smART+ Platform has shown that it can maximize feeding efficiency, achieving nearly 90% of the targeted nutrition goal, and enhance patient outcomes by reducing both the ICU length of stay and the length of ventilation by 3.3 days. This significant advancement paves the way for the commercialization of ART MEDICAL’s revolutionary technology.
HospiMedica, July 26, 2023

ART MEDICAL, an Israeli medical device company committed to its vision of detecting and preventing intensive care unit (ICU)-acquired complications such as aspiration pneumonia, malnutrition and acute kidney injury, unveiled unprecedented results on the performance of its smART+ Platform in a randomized comparative study published by the European Society for Clinical Nutrition and Metabolism’s (ESPEN’s) Clinical Nutrition.
Cision, July 24, 2023

ART MEDICAL Ltd. is pleased to announce its collaboration with Teva Israel. Under the terms of the agreement, Teva Israel will market and distribute ART MEDICAL’s ground-breaking smART+ Platform in Israel’s intensive care units. The smART+ Platform is a robotic-assisted technology that aims to reduce complications related to feeding tube malposition, malnutrition, VAP, and AKI.
Accesswire, March 16, 2023

In Beilinson Hospital, intensive care patients are now being treated using breakthrough technology – therapeutic medical devices for optimal nutrition and malnutrition prevention. It is the first department in the world to implement this advanced technology through ART MEDICAL’s smART+ platform.
Clalit, October 12, 2021

ART MEDICAL’s sensor-based platform collects new, and untapped patient data to reduce the risks of medical complications. ART MEDICAL is the first to develop advanced algorithms that automate the placement of feeding tubes, and detection of gastric content aspiration to improve clinical outcomes.
Dotmed, February 20, 2018

ART MEDICAL, a company based in Israel and Palo Alto, has products that seek to prevent complications that can arise from intubation, including aspiration pneumonia, VAP, and acute kidney injury. Such Complications can lengthen a patient’s stay in the hospital and increase their mortality risk.
Medcity, February 23, 2018

This company’s wide array of sensors and smart devices can warn what needs to be done to avoid fatal situations and sometimes automate them altogether. ART MEDICAL claims that this platform will save lives, as fewer people will be afflicted by hospital-acquired pneumonia.
Techworm, September 17, 2020

Pneumonia arising from the use of ventilators and feeding tubes in the ICU is disturbingly common and often life-threatening. ART MEDICAL, a company based in Netanya, Israel, has developed technology that may help prevent aspiration pneumonia and ventilator-associated pneumonia.
Medgadget, July 31, 2017

ART MEDICAL has developed a solution designed to reduce mortality among patients on respirators and fed through tubes: “When we show hospitals that we are lowering hospitalization costs, and even saving an average of one day of hospitalization in intensive care, the price of the system will no longer be an issue.”
Globes, June 08, 2017

The Israeli company is creating an intelligent feeding tube platform with integrated sensors and a monitoring system, enabling real-time responses to prevent medical complications.
Geektime, June 08, 2017